Entrada Therapeutics, Inc.TRDANASDAQ
LOADING
|||
EV to Sales: Premium Valuation
Trending lower, above historical average.
Left:
||||
Enterprise value to sales ratio
Latest
2.86
↑ 155% above average
Average (5y)
1.12
Historical baseline
Range
High:3.87
Low:0.00
Volatility
345.0%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 2.86 | -26.1% |
| 2023 | 3.87 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |